Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$191.51 - $216.16 $332 Million - $375 Million
-1,736,097 Reduced 77.03%
517,636 $110 Million
Q2 2023

Aug 14, 2023

SELL
$187.64 - $206.25 $859 Million - $944 Million
-4,575,730 Reduced 67.0%
2,253,733 $434 Million
Q1 2023

May 12, 2023

SELL
$127.59 - $203.08 $389 Million - $620 Million
-3,051,829 Reduced 30.88%
6,829,463 $1.38 Billion
Q4 2022

Feb 13, 2023

BUY
$117.37 - $139.17 $4.61 Million - $5.46 Million
39,243 Added 0.4%
9,881,292 $1.27 Billion
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $151 Million - $201 Million
1,117,428 Added 12.81%
9,842,049 $1.35 Billion
Q2 2022

Aug 15, 2022

SELL
$108.81 - $179.33 $408 Million - $673 Million
-3,751,404 Reduced 30.07%
8,724,621 $1.54 Billion
Q1 2022

May 16, 2022

BUY
$119.61 - $157.85 $100 Million - $132 Million
839,088 Added 7.21%
12,476,025 $1.8 Billion
Q4 2021

Feb 11, 2022

SELL
$142.57 - $190.86 $79.1 Million - $106 Million
-554,544 Reduced 4.55%
11,636,937 $1.8 Billion
Q3 2021

Nov 15, 2021

BUY
$142.45 - $169.82 $237 Million - $283 Million
1,663,797 Added 15.8%
12,191,481 $2.07 Billion
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $280 Million - $333 Million
2,070,041 Added 24.48%
10,527,684 $1.66 Billion
Q1 2021

May 17, 2021

BUY
$137.51 - $190.8 $384 Million - $533 Million
2,795,495 Added 49.37%
8,457,643 $1.17 Billion
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $932 Million - $1.2 Billion
5,662,148 New
5,662,148 $992 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.